EVMN NYSE
Evommune, Inc.
1W: -4.7%
1M: -38.9%
3M: -53.6%
YTD: -70.4%
$5.16
+0.03 (+0.58%)
Weekly Expected Move ±9.6%
$4
$5
$5
$6
$6
Credit Risk of going bust: higher than 76% of companies Debt: 4.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.05 (down 99.1%), Evommune, Inc. would be worth roughly what it owes.
Total debt $8.1M against a stock market value of $187.3M.
Distance to default 2.94 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.1M (short-term plus half of long-term), stock volatility 113.7%; Altman Z'' 10.89. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.05 (down 99.1%), Evommune, Inc. would be worth roughly what it owes.
Total debt $8.1M against a stock market value of $187.3M.
Distance to default 2.94 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.1M (short-term plus half of long-term), stock volatility 113.7%; Altman Z'' 10.89. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.